• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双膦酸盐用于乳腺癌:已解答的问题与尚存的问题

Bisphosphonates for breast cancer: questions answered, questions remaining.

作者信息

Layman Rachel, Olson Karin, Van Poznak Catherine

机构信息

Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109-0848, USA.

出版信息

Hematol Oncol Clin North Am. 2007 Apr;21(2):341-67. doi: 10.1016/j.hoc.2007.03.004.

DOI:10.1016/j.hoc.2007.03.004
PMID:17512453
Abstract

Bone is an important organ that is essential to adult hematopoiesis, electrolyte balance, and locomotion. Individuals who have metastatic breast cancer involving the bone are at increased risk for skeletal complications and those who have a history of early-stage breast cancer may be at increased risk for fragility fractures. Maintaining bone integrity is critical to control the morbidity and mortality associated with fractures and other skeletal complications. The bisphosphonates have been shown to be efficacious in decreasing the risk for skeletal complications in cancer and in osteoporosis. The article reviews the use of bisphosphonates in patients who have breast cancer.

摘要

骨骼是一个重要器官,对成人造血、电解质平衡和运动至关重要。患有骨转移乳腺癌的个体发生骨骼并发症的风险增加,而有早期乳腺癌病史的个体发生脆性骨折的风险可能增加。维持骨骼完整性对于控制与骨折和其他骨骼并发症相关的发病率和死亡率至关重要。双膦酸盐已被证明可有效降低癌症和骨质疏松症患者发生骨骼并发症的风险。本文综述了双膦酸盐在乳腺癌患者中的应用。

相似文献

1
Bisphosphonates for breast cancer: questions answered, questions remaining.双膦酸盐用于乳腺癌:已解答的问题与尚存的问题
Hematol Oncol Clin North Am. 2007 Apr;21(2):341-67. doi: 10.1016/j.hoc.2007.03.004.
2
New results from the use of bisphosphonates in cancer patients.双膦酸盐类药物在癌症患者中的应用新成果。
Curr Opin Support Palliat Care. 2009 Sep;3(3):213-8. doi: 10.1097/SPC.0b013e32832f4149.
3
Clinical efficacy and safety of zoledronic acid in prostate and breast cancer.唑来膦酸在前列腺癌和乳腺癌中的临床疗效与安全性。
Expert Rev Anticancer Ther. 2009 Sep;9(9):1211-8. doi: 10.1586/era.09.95.
4
Osteonecrosis of the jaw and bisphosphonate use in breast cancer patients.乳腺癌患者颌骨坏死与双膦酸盐的使用
Expert Rev Anticancer Ther. 2009 Aug;9(8):1125-34. doi: 10.1586/era.09.74.
5
Pharmacotherapy of bone metastases in breast cancer patients.乳腺癌患者骨转移的药物治疗
Expert Opin Pharmacother. 2008 Apr;9(6):937-45. doi: 10.1517/14656566.9.6.937.
6
Should bisphosphonates be utilized in the adjuvant setting for breast cancer?用于乳腺癌辅助治疗时,双磷酸盐类药物是否应该被使用?
Breast Cancer Res Treat. 2010 Aug;122(3):627-36. doi: 10.1007/s10549-010-0935-7. Epub 2010 May 21.
7
[Bisphosphonates and breast cancer].[双膦酸盐与乳腺癌]
Duodecim. 2010;126(10):1229-37.
8
Bisphosphonates in breast cancer: clinical activity and implications of preclinical data.双膦酸盐在乳腺癌中的应用:临床活性及临床前数据的意义
Clin Adv Hematol Oncol. 2011 Mar;9(3):194-205.
9
Routine adjuvant use of bisphosphonates in breast cancer arguments in favour and against.乳腺癌中双膦酸盐常规辅助使用的支持与反对观点
Crit Rev Oncol Hematol. 2010 Apr;74 Suppl 1:S11-5. doi: 10.1016/S1040-8428(10)70005-6.
10
Bisphosphonates--role in cancer therapies.双膦酸盐类——在癌症治疗中的作用
J Oral Maxillofac Surg. 2009 May;67(5 Suppl):19-26. doi: 10.1016/j.joms.2009.01.012.

引用本文的文献

1
Analysis of orthopedic surgery of bone metastases in breast cancer patients.乳腺癌患者骨转移的骨科手术分析。
BMC Musculoskelet Disord. 2012 Nov 27;13:232. doi: 10.1186/1471-2474-13-232.